Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort

Aims HNF1A gene mutations are the most common cause of maturity‐onset diabetes of the young (MODY) in the UK. Persons with HNF1A–MODY display sensitivity to sulphonylurea therapy; however, the long‐term efficacy is not established. There is limited literature as to the prevalence of micro‐ and macro...

Ausführliche Beschreibung